Brachyspira pilosicoli causes spirochetal diarrhea resulting in reduced growth and great economic losses in pig herds. The disease is treated with antibiotics but today we see an increased incidence of antibiotic resistance in the bacteria, which may lead to difficulties to treat the disease in the near future. How the
bacterium causes disease is unknown. We want to identify proteins of B. pilosicoli that the bacterium uses to attach to the intestinal mucosa. With knowledge of this process, we want to find ways to block the binding and thus probably prevent the onset of symptoms. The proteins may act as antigens for vaccine
development and may be used for development of new and specific diagnostic tests. We also want to develop a gut tissue model both for studying the binding of B. pilosicoli to the intestinal mucosa, and to test the effect of probiotic bacteria on the binding.